![PepVax, Inc.](/api/images/company-pic/0-184486-company.jpg)
Contáctenos
Acerca de la compañía
PepVax, Inc. has developed a novel DNA-based drug delivery and development platform, called SMARTmid™, to make safer and more effective treatments inside the patient (Intusic™) using a “Trojan Horse” approach. The company is currently focusing on treatment efforts for COVID-19.
US
Desconocido
Empresa no verificada
Transparencia empresarial
- No verificó la información de la empresa
- Pide reseñas a sus clientes
- No respondió a las críticas negativas.